Exploring the possibility of a predictable precision therapy of COPD with inclusion of glycopyrronium responsiveness: A real-world experience

Background: The advent of glycopyrronium responsiveness has opened the prospect of selective responsiveness-based prescription of bronchodilators-β2-agonists or anti-muscarinic agents (AMA) for COPD. Such a concept needs ratification through clinical trials. Methods: Stable COPD patients [post-bronc...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Parthasarathi Bhattacharyya, Shuvam Ghosh, Srijita Sen, Debkanya Dey, Sayoni Sengupta, Saayon Bej, Avishek Kar, Dipanjan Saha
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Wolters Kluwer Medknow Publications 2025-07-01
סדרה:	Lung India
נושאים:	copd glycopyrronium responsiveness precision therapy real-world trough fev1 total fev1 improvement
גישה מקוונת:	https://journals.lww.com/10.4103/lungindia.lungindia_54_25
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!